misleading statements

Class action lawsuit filed against Corcept Therapeutics alleging false statements about relacorilant drug's clinical strength and FDA approval prospects.

Mereo BioPharma faces class action lawsuit alleging false statements about failed Phase 3 clinical trials. Investors can join by April 6, 2026.

Schall Law Firm launches class action against $ALDX over alleged false statements regarding reproxalap drug candidate. Investors who bought securities Nov 2023-Mar 2026 can join before May 29 deadline.

Schall Law Firm seeks $PSIX investors for securities fraud lawsuit over allegedly false data center business statements and hidden manufacturing costs.

Class action lawsuit filed against Navan ($NAVN) alleging IPO securities fraud over undisclosed sales/marketing spending requirements. Deadline to join: April 24, 2026.

$CORT faces securities fraud lawsuit alleging false statements about relacorilant's FDA approval status. Investors from October 2024-December 2025 can join class action with Schall Law Firm.

PayPal faces securities fraud lawsuit over alleged misrepresentations about Branded Checkout growth and salesforce capabilities during 2025-2026 period.

Tennant Company faces securities fraud probe after ERP implementation caused $30M sales loss, $20M remediation costs. Stock crashed 23.4% on disclosure.

Vital Farms faces class action lawsuit alleging material misstatements about ERP system implementation risks that harmed shareholder value. May 26 deadline for participation.

Law firm investigating $TBPH for alleged misleading statements about CYPRESS trial and cash burn during enrollment phase that preceded trial failure.

Rosen Law Firm files securities class action against $ALDX over alleged misleading statements regarding reproxalap clinical trial results. Lead plaintiff deadline set for May 29, 2026.

Rosen Law Firm reminds PomDoctor ($POM) investors of April 7, 2026 deadline to join securities class action alleging fraud, insider trading, and social media manipulation.

Rosen Law Firm files class action against Vital Farms over alleged misstatements regarding ERP system delays that caused missed 2025 earnings guidance.

Coty faces securities litigation after revealing 70% Consumer Beauty income decline versus November guidance. CEO departure and withdrawn guidance triggered 8% stock drop.

Class action lawsuit filed against $MNDY alleging misleading revenue outlook. Investors have until May 11 to claim lead plaintiff status.

uniQure faces securities class action over alleged FDA disclosure failures; investors have until April 13, 2026, to join litigation seeking damages.

Rosen Law Firm files securities class action against Trip.com Group ($TCOM), alleging false statements on business operations and regulatory risks. Investors urged to secure counsel before deadlines.

Hercules Capital ($HTGC) sued for securities fraud over alleged misleading valuation statements. Stock dropped 7.9% in February; investors can seek lead plaintiff status.

Richtech Robotics ($RR) faces securities lawsuit after Microsoft denied partnership claims that triggered 30% stock surge, followed by 20% plunge.

Rosen Law Firm urges Snowflake investors to join securities class action alleging the company made misleading statements while concealing material negative information, causing stock price losses.